Published in Mol Cell Biol on December 01, 2000
A common signaling cascade may underlie "addiction" to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell (2006) 3.78
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A (2001) 3.29
SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol (2004) 1.70
Differing Src signaling levels have distinct outcomes in Drosophila. Cancer Res (2007) 1.13
Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik. Cell Death Differ (2012) 0.88
Cellular processes of v-Src transformation revealed by gene profiling of primary cells--implications for human cancer. BMC Cancer (2010) 0.87
Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells. J Cell Physiol (2009) 0.86
Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes. Exp Cell Res (2012) 0.84
v-Src Causes Chromosome Bridges in a Caffeine-Sensitive Manner by Generating DNA Damage. Int J Mol Sci (2016) 0.80
Mouse mammary tumor virus suppresses apoptosis of mammary epithelial cells through ITAM-mediated signaling. J Virol (2012) 0.79
Pleiotropic action of AP-1 in v-Src-transformed cells. J Virol (2011) 0.78
Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis. Int J Mol Sci (2017) 0.75
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Mitochondria and apoptosis. Science (1998) 23.41
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 21.42
Stat3 as an oncogene. Cell (1999) 17.39
Death receptors: signaling and modulation. Science (1998) 16.95
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (1997) 16.09
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (1997) 15.25
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (1998) 11.70
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (1999) 11.37
Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol (1997) 11.36
Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev (1998) 9.03
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature (1999) 8.42
Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol (1999) 8.21
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity (1999) 7.78
Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature (1999) 7.66
Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science (1999) 7.37
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev (1993) 6.02
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (1999) 5.33
A matter of life and cell death. Science (1998) 5.33
Requirement for c-ras proteins during viral oncogene transformation. Nature (1986) 5.24
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Mediation of c-Myc-induced apoptosis by p53. Science (1994) 4.45
Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol (1998) 4.22
Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol (1998) 4.09
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A (1997) 4.07
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol (1999) 4.03
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev (1994) 3.70
PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci (1997) 3.68
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol (1992) 3.37
The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol (2000) 3.34
The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev (1999) 3.25
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol (1997) 3.03
Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet (1999) 2.84
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science (1997) 2.52
The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev (1996) 2.06
Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem (1998) 1.86
New roles for Src kinases in control of cell survival and angiogenesis. Cell (2000) 1.83
Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol (1999) 1.80
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res (1999) 1.71
Action of Myc in vivo - proliferation and apoptosis. Curr Opin Genet Dev (2000) 1.69
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia (1999) 1.45
Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol (2000) 1.44
Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene (1999) 1.41
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell (1999) 1.35
Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene (1991) 1.35
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol Cell (1999) 1.34
Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol (1999) 1.26
Cell proliferation and apoptosis. Curr Opin Cell Biol (1999) 1.21
Traps to catch unwary oncogenes. Trends Genet (1998) 1.19
Regulation of both apoptosis and cell survival by the v-Src oncoprotein. Cell Death Differ (2000) 1.18
Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence. Oncogene (1998) 1.12
Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol Cell (1995) 1.10
Ras-independent transformation by v-Src. Proc Natl Acad Sci U S A (1997) 1.07
Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol Cell Biol (1997) 1.03
Full oncogenic activities of v-Src are mediated by multiple signaling pathways. Ras as an essential mediator for cell survival. J Biol Chem (2000) 0.95
Cancer--a matter of life and cell death. Int J Cancer (1997) 0.95
Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle. Oncogene (1990) 0.94
Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene (1997) 0.90
NSAID-induced apoptosis in Rous sarcoma virus-transformed chicken embryo fibroblasts is dependent on v-src and c-myc and is inhibited by bcl-2. Prostaglandins (1997) 0.88
Mitogenesis by v-Src: a need for active oncoprotein both in leaving G0 and in completing G1 phases of the cell cycle. Cell Growth Differ (1993) 0.84
Proliferation of chicken neuroretina cells induced by v-src, in vitro, depends on activation of the E2F transcription factor. Oncogene (1997) 0.79
The fission yeast cdc18+ gene product couples S phase to START and mitosis. Cell (1993) 6.25
Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature (1970) 5.66
Long-term developmental outcome of infants with iron deficiency. N Engl J Med (1991) 5.51
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
Transformation by Rous sarcoma virus: effects of src gene expression on the synthesis and phosphorylation of cellular polypeptides. Proc Natl Acad Sci U S A (1979) 4.18
Src homology region 2 domains direct protein-protein interactions in signal transduction. Proc Natl Acad Sci U S A (1990) 4.13
The a subunit in the RNA of transforming avian tumor viruses. I. Occurrence in different virus strains. II. Spontaneous loss resulting in nontransforming variants. Virology (1972) 3.95
Glycoprotein components of avian and murine RNA tumor viruses. Virology (1970) 3.92
Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics (2000) 3.79
Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell (1980) 3.70
Specific RNA sequences and gene products of MC29 avian acute leukemia virus. Proc Natl Acad Sci U S A (1978) 3.22
Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18
Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci U S A (1971) 2.83
Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics (1987) 2.74
Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol (1991) 2.69
Cell-free translation of virion RNA from nondefective and transformation-defective Rous sarcoma viruses. J Virol (1976) 2.68
A strain of Fujinami sarcoma virus which is temperature-sensitive in protein phosphorylation and cellular transformation. Cell (1980) 2.61
Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. Proc Natl Acad Sci U S A (1989) 2.35
Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine. Nature (1984) 2.21
Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell (1985) 2.16
Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci U S A (1994) 2.14
Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med (2000) 2.10
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis (1998) 2.08
Structure and function of Cdc6/Cdc18: implications for origin recognition and checkpoint control. Mol Cell (2000) 2.07
Platelet tyrosine-specific protein phosphorylation is regulated by thrombin. Mol Cell Biol (1988) 2.01
Linker insertion-deletion mutagenesis of the v-src gene: isolation of host- and temperature-dependent mutants. J Virol (1989) 1.95
Rate of Glycolate Formation During Photosynthesis at High pH. Plant Physiol (1966) 1.94
Novel yeast protein kinase (YPK1 gene product) is a 40-kilodalton phosphotyrosyl protein associated with protein-tyrosine kinase activity. Mol Cell Biol (1990) 1.93
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception (1990) 1.84
Structural basis for the interaction of Ras with RalGDS. Nat Struct Biol (1998) 1.80
Transformation-defective mutants of avian sarcoma viruses: the genetic relationship between conditional and nonconditional mutants. Virology (1976) 1.75
Protein-tyrosine kinase activity in Saccharomyces cerevisiae. Science (1986) 1.68
Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells. Mol Cell Biol (1987) 1.65
Membrane association of a 36,000-dalton substrate for tyrosine phosphorylation in chicken embryo fibroblasts transformed by avian sarcoma viruses. J Cell Biol (1983) 1.65
Myocardial bridge as a cause of thrombus formation and myocardial infarction in a young athlete. Clin Cardiol (1997) 1.64
Agglutination of cells transformed by Rous sarcoma virus by wheat germ agglutinin and concanavalin A. Nat New Biol (1972) 1.53
A conserved domain regulates interactions of the v-fps protein-tyrosine kinase with the host cell. Proc Natl Acad Sci U S A (1987) 1.51
Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development (1999) 1.50
Postzoster cutaneous pseudolymphoma. Arch Dermatol (1994) 1.50
Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein pp60src. Mol Cell Biol (1982) 1.49
Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J Pediatr (1996) 1.44
The epidemiology of Entamoeba histolytica in Mexico City. A pilot survey I. Trans R Soc Trop Med Hyg (1980) 1.43
Nucleotidylation, not phosphorylation, is the major source of the phosphotyrosine detected in enteric bacteria. J Bacteriol (1989) 1.42
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS (1998) 1.40
Identification of a 42-kilodalton phosphotyrosyl protein as a serine(threonine) protein kinase by renaturation. Mol Cell Biol (1990) 1.38
Mutants of Rous sarcoma virus with extensive deletions of the viral genome. Virology (1979) 1.37
Ubiquitin-dependent degradation of active Src. Curr Biol (1999) 1.36
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell (1999) 1.35
env Gene of Rous sarcoma virus: identification of the gene product by cell-free translation. J Virol (1980) 1.28
Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets. J Biol Chem (1989) 1.27
The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol (2001) 1.21
Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg (2001) 1.21
Cell-free translation of avian erythroblastosis virus RNA. J Virol (1980) 1.20
Viral transformation of rat myoblasts: effects on fusion and surface properties. Dev Biol (1976) 1.17
Cellular localization of c-fps gene product NCP98. J Virol (1984) 1.16
Overexpression of the yeast MCK1 protein kinase suppresses conditional mutations in centromere-binding protein genes CBF2 and CBF5. Mol Gen Genet (1995) 1.15
Casein kinase II catalyzes tyrosine phosphorylation of the yeast nucleolar immunophilin Fpr3. J Biol Chem (1997) 1.15
Ras-independent activation of Ral by a Ca(2+)-dependent pathway. Curr Biol (1998) 1.14
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 1.11
Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene (2000) 1.08
Ras-independent transformation by v-Src. Proc Natl Acad Sci U S A (1997) 1.07
Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants. J Infect Dis (1999) 1.05
Yeast MCK1 protein kinase autophosphorylates at tyrosine and serine but phosphorylates exogenous substrates at serine and threonine. J Biol Chem (1993) 1.03
Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus. J Am Vet Med Assoc (1987) 1.03
Viral transformation of chick myogenic cells. The relationship between differentiation and the expression of the SRC gene. Exp Cell Res (1979) 1.01
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. J Infect Dis (2001) 1.01
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. J Infect Dis (2000) 1.01
No evidence of developmental III effects of low-level lead exposure in a developing country. J Dev Behav Pediatr (1994) 1.00
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Med (2008) 0.99
Cellular localization of the transforming protein of wild-type and temperature-sensitive Fujinami sarcoma virus. J Virol (1984) 0.98
Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts. Oncogene (1992) 0.98
The tyrosine phosphorylation substrate p36 is developmentally regulated in embryonic avian limb and is induced in cell culture. J Cell Biol (1986) 0.98
Methods for accelerating the fluorescent-antibody test for rabies diagnosis. Appl Microbiol (1971) 0.97
pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus. Proc Natl Acad Sci U S A (1988) 0.97
Nonenzymatic phosphorylation of tyrosine and serine by ATP is catalyzed by manganese but not magnesium. J Biol Chem (1988) 0.97
Rapidly fatal infection with Ehrlichia chaffeensis. N Engl J Med (1999) 0.96
Assessing activities of blotted protein kinases. Methods Enzymol (1991) 0.95
Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis. Antimicrob Agents Chemother (2000) 0.95
Three-dimensional structure of the Ras-interacting domain of RalGDS. Nat Struct Biol (1997) 0.95
The 60-70S RNA of avian sarcoma and leukosis viruses--distribution of class a and b subunits. Bibl Haematol (1973) 0.94
Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae. Mol Biol Cell (1994) 0.92
Host range mutants of v-src: alterations in kinase activity and substrate interactions. J Virol (1992) 0.92
Transformation by Rous sarcoma virus: effects of src-gene expression on the synthesis and phosphorylation of cellular polypeptides. Cold Spring Harb Symp Quant Biol (1980) 0.92
Arthroscopic anatomy of the intercarpal and radiocarpal joints of the horse. Equine Vet J (1985) 0.92
Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol (1998) 0.92
Cas mediates transcriptional activation of the serum response element by Src. Mol Cell Biol (1999) 0.91
Transformation parameters of chick embryo fibroblasts transformed by Fujinami, PRCII, PRCII-p, and Y73 avian sarcoma viruses. Virology (1982) 0.91
The yeast immunophilin Fpr3 is a physiological substrate of the tyrosine-specific phosphoprotein phosphatase Ptp1. J Biol Chem (1995) 0.89
Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation (1992) 0.89
Intracellular localization of pp60c-src in human platelets. Oncogene (1990) 0.88
Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer (1998) 0.87
Osteolysis associated with cemented total knee arthroplasty. J Arthroplasty (1998) 0.86
Human immunodeficiency virus-related lymphoreticular malignancies and peripheral neurologic disease. A report of four cases. Cancer (1988) 0.86